Colonic spreading of a non‐chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis
Authors:
- 1 April 1995
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 9 (2) , 161-166
Abstract
Background: Rectal foam enemas provide for drug delivery to the distal colon for treatment of left sided ulcerative colitis. However, currently available formulations contain chlorofluorocarbons which are due to be phased out in the near future. The objective of this study was therefore to determine the degree of dispersion of a newly developed nonchlorofluorocarbon rectal foam preparation in ulcerative colitis patients. Methods: This was an open label non-controlled study of a single administration of a mesalazine foam enema (two actuations containing 2 g of mesalazine in approximately 120 mL foam) in 10 patients with quiescent ulcerative colitis. Spreading of the 99mTc-labelled foam enema was assessed over a 4-h period by the non-invasive technique of gamma scintigraphy. Results: All patients retained the enema for the full 4-h imaging period. In nine out of the 10 patients, the enema was observed to spread as far as the descending colon and on average 23% of the dose was present in the descending colon at 4 h post-dose. Conclusions: The extent of spreading observed in the study supports the use of the formulation in the treatment of left sided ulcerative colitis.Keywords
This publication has 19 references indexed in Scilit:
- Better quality of therapy with 5-ASA colonic foam in active ulcerative colitisDigestive Diseases and Sciences, 1993
- Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitisDigestive Diseases and Sciences, 1992
- Mesalazine (5-Aminosalicylic Acid) Suppositories in the Treatment of Ulcerative Proctitis or Distal Proctosigmoiditis: A Randomized Controlled TrialScandinavian Journal of Gastroenterology, 1990
- Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using99mTc-labeled 5-ASA suppositoriesDigestive Diseases and Sciences, 1987
- Evaluation of an enteric‐coated delayed‐release 5‐aminosalicylic acid tablet in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 1987
- Gastrointestinal transit of an enteric‐coated delayed‐release 5‐aminosalicylic acid tabletAlimentary Pharmacology & Therapeutics, 1987
- Enema volume and spreadingInternational Journal of Pharmaceutics, 1986
- The spreading of foam and solution enemasInternational Journal of Pharmaceutics, 1985
- Validity of the geometric mean correction in the quantification of whole bowel transitNuclear Medicine Communications, 1985
- Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.BMJ, 1979